Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Clinical trial NCT06950697 · RECRUITING

Trial details

NCT number: NCT06950697
Sponsor: Beijing Chao Yang Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Lung Cancer Venous Thromboembolism Arterial Thromboembolism Immune Checkpoint Inhibitors (ICIs)

Start date: 2019-01-01
Primary completion: 2026-12-31
Enrollment: 2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.